Reference
NICE. National Institute for Health and Clinical Excellence. Final appraisal determination - Talimogene laherparepvec for treating unresectable metastatic melanoma. Internet Document : 9 Aug 2016. Available from: URL: https://www.nice.org.uk/guidance/GID-TAG509/documents/final-appraisal-determination-document
Rights and permissions
About this article
Cite this article
Final draft guidance on melanoma treatment, Imlygic. PharmacoEcon Outcomes News 760, 36 (2016). https://doi.org/10.1007/s40274-016-3337-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3337-1